We believe in life after stroke. That’s why we actively campaign for better stroke care, working with politicians of all parties to ensure stroke remains high on the political agenda. It's why we fund research into finding new treatments, and also ways of reducing the risk of stroke across the UK. Find out what we're upto currently in Scotland.
Exploring the effects of lowering blood pressure and a lower dose of clot busting drug on stroke outcome
High blood pressure is one of the biggest risk factors for stroke. It is a contributing factor in around half of all strokes.
High blood pressure is the biggest risk factor for stroke. In the UK, 9.5 million people are diagnosed with high blood pressure, with a further 5.5 million cases undiagnosed. This guide explains the link between high blood pressure and stroke, the medication used to treat it and some steps you can take to lower your blood pressure.
Over 3500 delegates attended the 2nd European Stroke Organisation Conference (ESOC 2016) today in Barcelona. Today’s program included teaching courses, scientific presentations, an official welcome from the ESOC President Professor Kennedy Lees and from Professor Angel Chamorro, and presentations from major clinical trials.
During February and March pharmacies across Wales are joining the Lower Your Risk of Stroke campaign, a partnership between Community Pharmacy Wales, Public Health Wales and the Stroke Association.
This study will show whether more intensive lowering of blood pressure (BP) in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury. If successful, the study will pave the way for the design a larger definitive trial.
Take a Moment to order your free Blood Pressure Information Pack today to enjoy more moments doing what you love, with the people you love.
Our Blood Pressure Information Pack tells you where you can get your blood pressure tested to help reduce your risk of stroke.
Reducing blood pressure to prevent bleeding complications and improve outcome following clot-busting treatment for ischaemic stroke